Porvair Launches Genuine 2 mL Deep Well Plate
Porvair Sciences has developed the first 96-well round deep well plate that genuinely delivers 2.00 mL liquid capacity/well in an automation compatible SLAS/ANSI footprint. The revolutionary "common wall" design provides a full 2 mL round well, round bottom well within a 45-mm height limit, thus ensuring full compatibility with most plate handling equipment.
Unlike other '2 mL' deep well plates that typically offer just 1.80–1.90 mL well, the new Porvair plate enables labs involved with fraction collecting, compound storage, plate replication and mixing applications the chance to use the full 2.00 mL well capacity without compromise.
Manufactured under class 10,000 conditions from ultra-pure grade polypropylene, Porvair's new 2.00 mL 96-well deep well plates are certified as RNase/DNase free and contain no measurable contaminants that could otherwise leach out and affect the sample. For sterile biological applications, Porvair 2.00 mL 96-well deep well plates are available irradiated. A matching thermoplastic elastomer "cap mat" provides easy friction sealing of this new plate for transport, shipping and short-term storage. For longer periods, the new 2.00 mL plate can be heat sealed using Porvair Sciences aluminium or clear heat seals together with the company's Miniseal II thermal sealer to provide a range of peelable, peirceable and re-sealable storage options.
Measuring just 45 mm high, Porvair 2.00 mL 96-well deep well plates are compatible with microplate stackers, washers and automated equipment. The new plate design incorporates features that prevent 'locking' when stacked and enable easy heat sealing.
Related News
-
News Eli Lilly’s Alzheimer’s drug receives approval from US FDA
After facing several hurdles on its path to approval last year, Eli Lilly’s donanemab treatment for early Alzheimer’s, brand name Kisunla, received US FDA approval this past week. It is the second therapy for slowing the progression of Alzh... -
News This week in GLP-1 drug headlines: Manufacturing investment and new market launches
As drugmakers race to put their own GLP-1 drug products forward as the next biggest thing in weight-loss, current products are making numerous headlines this week with a number of new developments in their commercialisation and approval. Discover the l... -
News Women in Pharma: Regulating equity across regional borders
In our monthly series focusing on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Viral marketing for B2B pharma businesses: a CPHI Online case study
Discover how a Chinese chemical manufacturing company went viral on TikTok, and what their viral success means for the future of B2B digital marketing for the wider pharmaceutical industry and supply chain. -
News New Aurigene biologics facility opens in Hyderabad, India
Aurigene Pharmaceutical Services Ltd. have opened a biologics facility in Hyderabad, India in a biocluster known as Genome Valley. -
News Novo Nordisk launches 'Power of Wegovy' national campaign
Danish drugmaker Novo Nordisk have launched a new national campaign – The Power of Wegovy – that aims to educate those living with obesity on their blockbuster drug Wegovy throughout the United States. -
News Women in Pharma Anniversary: Celebrating Our Heroines of Pharma
Our Women in Pharma interview series is approaching its 1-year anniversary this month, and to celebrate, we are highlighting the Heroines of Pharma that our very own Women in Pharma admire. -
News Sanofi gains rare disease therapy in acquisition of Inhibrx for US$1.7 billion
Sanofi completed the acquisition of the clinical-stage biotech company Inhibrx in late May 2024 after settling on a US$1.7 billion buyout. The acquisition brings with it a rare disease therapy to bollster Sanofi's pipeline.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance